Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:associated_with |
liver function tests
|
| gptkbp:clinical_trial |
diagnosis of heart diseases
diagnosis of liver diseases |
| gptkbp:established |
certain drugs
|
| gptkbp:first_described_by |
1950s
|
| gptkbp:form |
cytosolic AST
mitochondrial AST |
| gptkbp:genetic_diversity |
GO T1
GO T2 |
| https://www.w3.org/2000/01/rdf-schema#label |
aspartate aminotransferase
|
| gptkbp:increased |
gptkb:hospital
liver damage |
| gptkbp:indication |
vitamin B6 deficiency
|
| gptkbp:is_found_in |
gptkb:healthcare_organization
gptkb:automobile liver |
| gptkbp:is_involved_in |
amino acid metabolism
|
| gptkbp:is_known_for |
serum glutamate-oxaloacetate transaminase (SGOT)
|
| gptkbp:is_tested_for |
serum enzyme assay
|
| gptkbp:material |
alpha-ketoglutarate
aspartate |
| gptkbp:measures |
blood tests
|
| gptkbp:products |
glutamate
oxaloacetate |
| gptkbp:range |
10 to 40 U/ L in adults
5 to 55 U/ L in children |
| gptkbp:related_to |
alanine aminotransferase
|
| gptkbp:symbol |
AST
|
| gptkbp:was_a_catalyst_for |
the conversion of aspartate and alpha-ketoglutarate to oxaloacetate and glutamate
|
| gptkbp:bfsParent |
gptkb:CPK
|
| gptkbp:bfsLayer |
7
|